Envista (NVST) Revenue & Revenue Breakdown
Envista Revenue Highlights
Latest Revenue (Y)
$2.57B
Latest Revenue (Q)
$884.70M
Main Segment (Y)
Specialty Products and Technologies
Main Geography (Y)
UNITED STATES
Envista Revenue by Period
Envista Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $2.57B | -0.10% |
2022-12-31 | $2.57B | 2.40% |
2021-12-31 | $2.51B | 9.94% |
2020-12-31 | $2.28B | -17.07% |
2019-12-31 | $2.75B | -3.27% |
2018-12-31 | $2.84B | 1.20% |
2017-12-31 | $2.81B | 0.92% |
2016-12-31 | $2.79B | - |
Envista Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-27 | $884.70M | 39.74% |
2024-06-28 | $633.10M | 1.52% |
2024-03-29 | $623.60M | -3.41% |
2023-12-31 | $645.60M | 2.27% |
2023-09-29 | $631.30M | -4.70% |
2023-06-30 | $662.40M | 5.61% |
2023-03-31 | $627.20M | -5.08% |
2022-12-31 | $660.80M | 4.71% |
2022-09-30 | $631.10M | -2.28% |
2022-07-01 | $645.80M | 2.28% |
2022-04-01 | $631.40M | -3.13% |
2021-12-31 | $651.80M | 7.33% |
2021-10-01 | $607.30M | -17.94% |
2021-07-02 | $740.10M | 4.36% |
2021-04-02 | $709.20M | -3.15% |
2020-12-31 | $732.30M | 14.33% |
2020-10-02 | $640.50M | 76.93% |
2020-07-03 | $362.00M | -33.85% |
2020-04-03 | $547.20M | -24.05% |
2019-12-31 | $720.50M | 9.28% |
2019-09-27 | $659.30M | -7.41% |
2019-06-30 | $712.10M | 7.94% |
2019-03-31 | $659.70M | -13.08% |
2018-12-31 | $759.00M | 11.70% |
2018-09-30 | $679.50M | -7.35% |
2018-06-30 | $733.40M | 9.04% |
2018-03-31 | $672.60M | - |
Envista Revenue Breakdown
Envista Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Equipment and Consumables | $924.10M | - | - | - | - |
Specialty Products and Technologies | $1.64B | - | - | - | - |
Consumables | - | $2.15B | $2.07B | $1.59B | $1.87B |
Equipment Sales | - | $421.60M | $441.00M | $687.90M | $881.70M |
Latest
Quarterly Revenue by Product
Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Apr 22 | Dec 21 | Oct 21 | Jul 21 | Apr 21 | Dec 20 | Oct 20 | Jul 20 | Apr 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Specialty Products and Technologies | $408.70M | $825.90M | $399.50M | $417.00M | $328.80M | $317.80M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Equipment and Consumables | $214.90M | $446.90M | $231.80M | $245.40M | $391.70M | $341.50M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Equipment Sales | - | - | - | - | $91.70M | $119.00M | $100.10M | $101.00M | $101.50M | $125.50M | $113.60M | $205.60M | $194.30M | $231.30M | $180.60M | $106.70M | $169.30M | - | - |
Consumables | - | - | - | - | $535.50M | $541.80M | $531.00M | $544.80M | $529.90M | $526.30M | $493.70M | $534.50M | $514.90M | $501.00M | $459.90M | $255.30M | $377.90M | - | - |
Latest
Envista Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
CHINA | $205.70M | $222.20M | $236.70M | $215.60M | $212.80M |
All Other Countries | $1.15B | $1.08B | $1.05B | $908.90M | $1.18B |
UNITED STATES | $1.21B | $1.26B | $1.22B | $1.01B | $1.21B |
GERMANY | - | - | - | $144.60M | $151.30M |
Latest
Quarterly Revenue by Country
Country | Sep 24 | Mar 24 | Sep 23 | Dec 21 | Dec 19 |
---|---|---|---|---|---|
Western Europe | $109.30M | $148.30M | $119.50M | $135.40M | $160.00M |
North America | $319.50M | $318.70M | $332.00M | $333.50M | $351.20M |
Latest
Envista Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ALC | Alcon | $10.09B | $2.46B |
RMD | ResMed | $4.69B | $1.22B |
HOLX | Hologic | $4.03B | $1.01B |
COO | Cooper Companies | $3.59B | $1.00B |
ATR | AptarGroup | $3.49B | $909.29M |
TFX | Teleflex | $2.97B | $764.38M |
WST | West Pharmaceutical Services | $2.95B | $746.90M |
NVST | Envista | $2.57B | $884.70M |
ICUI | ICU Medical | $2.26B | $589.13M |
HAE | Haemonetics | $1.31B | $336.17M |
MMSI | Merit Medical Systems | $1.26B | $339.85M |
ATRC | AtriCure | $399.25M | $115.91M |
ANGO | AngioDynamics | $303.91M | $67.49M |
AKYA | Akoya Biosciences | $96.63M | $18.81M |
ATRI | Atrion | - | $48.77M |